InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Miller Andrew Craig, 管理人员. Officer active across 2 companies, notably Karuna Therapeutics, Inc.. In total, 15 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €230k. History available since 10 May 2021. The latest transaction was filed on 24 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Miller Andrew Craig
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
11,006 股0Common StockSEC:0001193125-26-091626:0
13,977 股@ US$330.0073.7% 占其流量Common StockSEC:0001140361-24-013930:0
1,011 股@ US$317.145.2% 占其流量Common StockSEC:0000950170-24-013962:0
30,000 股@ US$9.204.4% 占其流量Common StockSEC:0000950170-23-013722:0
12,550 股0Common StockSEC:0001593968-23-000302:0
7,100 股@ US$2.920.3% 占其流量Common StockSEC:0001593968-22-001764:0
250 股@ US$7.270.0% 占其流量Common StockSEC:0001593968-22-001691:0
1,000 股@ US$7.270.1% 占其流量Common StockSEC:0001593968-22-001596:0
2,000 股@ US$2.920.1% 占其流量Common StockSEC:0001593968-22-001570:0
26,500 股@ US$2.921.3% 占其流量Common StockSEC:0001593968-21-002357:0
700 股@ US$118.551.4% 占其流量Common StockSEC:0001593968-21-002238:0
1,590 股@ US$117.873.0% 占其流量Common StockSEC:0001593968-21-002085:0
12,500 股@ US$2.920.6% 占其流量Common StockSEC:0001593968-21-001993:0
13,333 股@ US$9.201.9% 占其流量Common StockSEC:0001593968-21-001617:0
5,000 股@ US$9.200.7% 占其流量Common StockSEC:0001593968-21-001293:0
15 条申报中的 15 条
About Miller Andrew Craig
Miller Andrew Craig is an executive linked to Karuna Therapeutics, Inc., where he is President of R&D, and to Kyverna Therapeutics, Inc., where he is Director. He has 15 filings in total, and across the recent filings observed, the transactions cover the period from 2021-05-12 to 2026-03-04, with 0 in buys and 4468316 in sells; the most frequent transaction nature is Option exercise.
